Log in

Diosmetin Alleviates Ovalbumin-Induced Nasal Inflammation by Regulating the SIRT1/NF-κB Signaling in Mouse Models of Allergic Rhinitis

  • Original Article
  • Published:
Revista Brasileira de Farmacognosia Aims and scope Submit manuscript

Abstract

Diosmetin is a flavonoid compound with various pharmacological activities, which plays a vital role in alleviating the development of asthma and atopic dermatitis. However, the role of diosmetin in allergic rhinitis is unclear. Our study aimed to investigate the effects of diosmetin on AR progression and the underlying molecular mechanisms. The allergic rhinitis murine model was established via ovalbumin challenge, followed by administration with diosmetin or dexamethasone. Before mice were sacrificed, nasal symptoms were evaluated. The histopathological examination of nasal mucosa was performed through hematoxylin–eosin and toluidine blue staining. The levels of histamine, ovalbumin-specific IgE, and ovalbumin-specific IgG1 in serum of mice and the levels of Th1/Th2-related cytokines and pro-inflammatory cytokines in nasal lavage fluid of mice were determined by enzyme-linked immunosorbent assay. The protein levels of silent information regulator 1 (SIRT1) and nuclear factor kappa B (NF-κB) pathway-related molecules were detected by western blotting. Diosmetin improved nasal symptoms, and downregulated the serum levels of histamine, IgE, and IgG1 in allergic rhinitis mice. Diosmetin attenuated eosinophil and mast cell infiltration in nasal mucosa tissues, decreased the migration of inflammatory cells into the nasal lavage fluid, and improved the Th1/Th2 cytokine imbalance in nasal lavage fluid. Diosmetin upregulated SIRT1 and inactivated the NF-κB pathway in allergic rhinitis mice. Furthermore, treatment with an SIRT1 inhibitor (EX-527) overturned the effects of diosmetin on the SIRT1/NF-κB signaling, Th1/Th2 cytokine imbalance, and nasal inflammation in allergic rhinitis mice. Diosmetin ameliorates nasal inflammation and Th1/Th2 imbalance by regulating the SIRT1/NF-κB signaling in allergic rhinitis mice.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.

References

Download references

Acknowledgements

The authors appreciate all the participants providing supports for this study.

Author information

Authors and Affiliations

Authors

Contributions

QH conceived and designed the experiments. QH and LP carried out the experiments, analyzed the data, and drafted the manuscript. All authors agreed to be accountable for all aspects of the work. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Lingyan Peng.

Ethics declarations

Ethics Approval and Consent to Participate

The Institutional Animal Care and Use Committee of Hubei Provincial Hospital of TCM (Wuhan, China) approved all experimental protocols.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, Q., Peng, L. Diosmetin Alleviates Ovalbumin-Induced Nasal Inflammation by Regulating the SIRT1/NF-κB Signaling in Mouse Models of Allergic Rhinitis. Rev. Bras. Farmacogn. 33, 1232–1242 (2023). https://doi.org/10.1007/s43450-023-00448-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43450-023-00448-w

Keywords

Navigation